How should I treat a patient with thyrotoxicosis presenting with severe anxiety and emotional lability who is currently taking paroxetine 30 mg daily?

Management of Severe Anxiety and Emotional Lability in Thyrotoxicosis

Beta-blockers (atenolol or propranolol) should be initiated immediately for symptomatic relief of anxiety and emotional lability in thyrotoxicosis, while continuing the patient's paroxetine and addressing the underlying thyroid dysfunction. 1

Immediate Symptomatic Management

Beta-Blocker Therapy

• Initiate beta-blocker therapy (atenolol or propranolol) as first-line treatment for symptomatic relief of anxiety, emotional lability, and other adrenergic symptoms in thyrotoxicosis 1
• Beta-blockers provide rapid relief of psychiatric symptoms including anxiety, restlessness, and emotional instability that are directly caused by excess thyroid hormone 2
• This intervention addresses the somatic manifestations while definitive thyroid treatment takes effect 1

Continue Current Psychiatric Medication

• Maintain the patient's paroxetine 30 mg daily, as SSRIs are appropriate for managing depression and anxiety in thyrotoxicosis 1
• Paroxetine does not significantly interfere with thyroid function and can help manage the psychiatric component 3, 4
• Preventive antidepressant therapy reduces occurrence of depression during thyroid treatment, though it does not increase cure rates 1

Thyroid-Specific Interventions

Grade Assessment and Treatment Intensity

• For Grade 1 (mild symptoms): Continue immune checkpoint inhibitor or thyroid treatment with beta-blockers and close monitoring 1
• For Grade 2 (moderate symptoms, able to perform activities of daily living): Consider holding thyroid-directed therapy temporarily until symptoms return to baseline, add endocrine consultation 1
• For Grade 3-4 (severe symptoms, unable to perform ADL): Hold thyroid treatment, hospitalize if needed, obtain urgent endocrine consultation for additional medical therapies including possible steroids 1

Monitoring Protocol

• Check TSH and free T4 every 2-3 weeks after diagnosis to catch the transition to hypothyroidism, which is the most common outcome 1
• T3 levels can be helpful in highly symptomatic patients with minimal free T4 elevations 1
• Continue monitoring thyroid function regularly for 1 year after treatment stabilization, as thyroid dysfunction can persist or emerge even after acute phase 1

Psychiatric Symptom Recognition

Thyrotoxicosis-Specific Psychiatric Manifestations

• Thyrotoxicosis commonly presents with emotional lability, anxiety, restlessness, and rarely frank psychosis 2
• Psychotic symptoms in hyperthyroidism typically present as affective psychosis rather than primary psychiatric disorder 2
• The psychiatric symptoms are directly caused by excess thyroid hormone and will improve with thyroid normalization 2

Monitoring for Progression

• Observe carefully for severe depression or suicidal ideation, which can occur during thyroid treatment and requires immediate intervention 1
• Approximately 28% of patients develop depression during thyroid treatment 1
• Neuropsychological problems including insomnia, difficulty concentrating, memory impairment, and irritability are common 1

Critical Clinical Pitfalls to Avoid

Do Not Attribute Everything to Primary Psychiatric Disease

• Always exclude thyroid dysfunction when assessing psychiatric symptoms—thyrotoxicosis is a somatic cause that must be treated first 2
• The link between psychosis and hyperthyroidism is poorly understood, but treating the underlying thyroid disorder is essential 2

Avoid Premature Discontinuation of Psychiatric Medications

• Do not discontinue the patient's paroxetine abruptly, as this could worsen anxiety during an already stressful physiologic state 1
• SSRIs like paroxetine have minimal thyroid interference compared to tricyclic antidepressants or phenothiazines 3, 4

Monitor for Autoimmune Complications

• Thyroid complications occur in 15-20% of patients and may include Hashimoto's disease (most common), which starts with hyperthyroidism and may progress to hypothyroidism 1
• Thyroid function may not recover even after cessation of treatment 1
• Check TSH and free thyroxine at 2-4 month intervals during treatment 1

Hydration and Supportive Care

• Provide adequate hydration and supportive care, particularly for Grade 2 or higher symptoms 1
• Address sleep disturbances, as insomnia exacerbates anxiety and emotional lability 1